NatureWise Biotech & Medicals Net Tangible Assets

As of the most recent data (June 2026), 4732.TWO shows a net tangible assets of $550M. That compares with $720M in the prior-year period — down 22.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4732.TWO's net tangible assets is now $550M (was $720M) — a 22.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NatureWise Biotech & Medicals is outperforming or lagging.

Tracking 4732.TWO's net tangible assets over time shows whether NatureWise Biotech & Medicals is scaling, shrinking, or reshaping that part of the business. The current reading is $550M That compares with $720M in the prior-year period — down 22.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has NatureWise Biotech & Medicals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $550M) with ownership activity and broader fundamentals.

NatureWise Biotech & Medicals's net tangible assets is $550M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.